Concepedia

Mark S. Khil

MS

Statistics

Publications

13

Citations

800

H-Index

13

Active since

1992

Affiliations

Henry Ford Hospital(Current)

Henry Ford Health System

Radiation Oncology Associates

Mark S. Khil is an author at Henry Ford Hospital specializing in radiation therapy, medicine, and oncology.

Publications per year

1992–2002

13

Publications

13

Phase I study of replication-competent adenovirus-mediated double suicide gene therapy for the treatment of locally recurrent prostate cancer.

Svend O. Freytag, Mark S. Khil, Hans Stricker et al. · PubMed · 2002 · 312 citations

Medicine, Oncology, Radiation Oncology +16

Potentiation of radiation response in human carcinoma cells in vitro and murine fibrosarcoma in vivo by topotecan, an inhibitor of DNA topoisomerase I

Jae Ho Kim, Sang Hie Kim, Andrew Kolozsvary et al. · International Journal of Radiation Oncology*Biology*Physics · 1992 · 108 citations · Full text

Medicine, Oncology, Pharmacology +17

Radiosensitization by 5-fluorocytosine of human colorectal carcinoma cells in culture transduced with cytosine deaminase gene.

Mark S. Khil, Jae Ho Kim, Craig A. Mullen et al. · PubMed · 1996 · 93 citations

Medicine, Oncology, Radiation Oncology +17

Preferential radiosensitization of human prostatic carcinoma cells by mild hyperthermia

Samuel Ryu, Stephen L. Brown, Sang-Hie Kim et al. · International Journal of Radiation Oncology*Biology*Physics · 1996 · 53 citations

Medicine, Cancer Biology, Oncology +15

Enhancement of radiation response on human carcinoma cells in culture by pentoxifylline

Sang Hie Kim, Mark S. Khil, Samuel Ryu et al. · International Journal of Radiation Oncology*Biology*Physics · 1993 · 35 citations · Full text

Medicine, Oncology, Radiation Oncology +14

1–5 of 13